Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2025-12-25 @ 1:12 AM
NCT ID:
NCT00542893
Eligibility Criteria:
Inclusion Criteria:
* Metastatic Stage IV disease, or Stage III disease that is not surgically resectable
* ECOG Performance Status of 0, 1, or 2
* Life expectancy of at least 12 weeks
* Adequate venous access
* Agreement to practice effective method of birth control
Exclusion Criteria:
* Less than 3 weeks of recovery from prior major surgery or other therapy, including radiation therapy, chemotherapy, or immunotherapy, or cytokine, biologic, or vaccine therapy
* Significant medical disease
* Known hypersensitivity to phosphorothioate-containing oligonucleotides
* Known hypersensitivity to DTIC
* Pregnancy/Lactation
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00542893
Study Brief:
Protocol Section:
NCT00542893